2-[2-[(4-Cyanophenyl)carbamoyl]phenyl]benzoic acid | 1172600-22-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-[2-[(4-Cyanophenyl)carbamoyl]phenyl]benzoic acid
• CAS: 1172600-22-4
• 化学式: C₂₁H₁₄N₂O₃
• 分子量: 342.354
• InChiKey: FANKNUUEOMQJSM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  26
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  90.2
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  甲醇 、 2-[2-[(4-Cyanophenyl)carbamoyl]phenyl]benzoic acid 在 盐酸 、 氨 作用下， 反应 32.0h， 以45%的产率得到methyl 2'-(4-carbamimidoylphenylcarbamoyl)biphenyl-2-carboxylate
  参考文献：
  名称：

  Design, parallel synthesis, and crystal structures of biphenyl antithrombotics as selective inhibitors of tissue factor FVIIa complex. Part 1: Exploration of S2 pocket pharmacophores

  摘要：

  Factor VIIa (FVIIa), a serine protease enzyme, coupled with tissue factor (TF) plays an important role in a number of thrombosis-related disorders. Inhibition of TF.FVIIa occurs early in the coagulation cascade and might provide some safety advantages over other related enzymes. We report here a novel series of substituted biphenyl derivatives that are highly potent and selective TF.FVIIa inhibitors. Parallel synthesis coupled with structure-based drug design allowed us to explore the S2 pocket of the enzyme active site. A number of compounds with IC50 value of <10 nM were synthesized. The X-ray crystal structures of some of these compounds complexed with TF.FVIIa were determined and results were applied to design the next round of inhibitors. All the potent inhibitors were tested for inhibition against a panel of related enzymes and selectivity of 17,600 over thrombin, 450 over trypsin, 685 over FXa, and 76 over plasmin was achieved. Two groups, vinyl 36b and 2-furan 36ab, were identified as the optimum binding substituents on the phenyl ring in the S2 pocket. Compounds with these two substituents are the most potent compounds in this series with good selectivity over related serine proteases. These compounds will be further explored for structure-activity relationship. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2009.04.013
• 作为产物：
  描述：

  N-(4-cyanophenyl)-2'-formyl-[1,1'-biphenyl]-2-carboxamide 在 sodium chlorite 、 sodium dihydrogenphosphate 、 2-甲基-2-丁烯 作用下， 以 水 、 乙腈 、 叔丁醇 为溶剂， 以46%的产率得到2-[2-[(4-Cyanophenyl)carbamoyl]phenyl]benzoic acid
  参考文献：
  名称：

  Design, parallel synthesis, and crystal structures of biphenyl antithrombotics as selective inhibitors of tissue factor FVIIa complex. Part 1: Exploration of S2 pocket pharmacophores

  摘要：

  Factor VIIa (FVIIa), a serine protease enzyme, coupled with tissue factor (TF) plays an important role in a number of thrombosis-related disorders. Inhibition of TF.FVIIa occurs early in the coagulation cascade and might provide some safety advantages over other related enzymes. We report here a novel series of substituted biphenyl derivatives that are highly potent and selective TF.FVIIa inhibitors. Parallel synthesis coupled with structure-based drug design allowed us to explore the S2 pocket of the enzyme active site. A number of compounds with IC50 value of <10 nM were synthesized. The X-ray crystal structures of some of these compounds complexed with TF.FVIIa were determined and results were applied to design the next round of inhibitors. All the potent inhibitors were tested for inhibition against a panel of related enzymes and selectivity of 17,600 over thrombin, 450 over trypsin, 685 over FXa, and 76 over plasmin was achieved. Two groups, vinyl 36b and 2-furan 36ab, were identified as the optimum binding substituents on the phenyl ring in the S2 pocket. Compounds with these two substituents are the most potent compounds in this series with good selectivity over related serine proteases. These compounds will be further explored for structure-activity relationship. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2009.04.013

文献信息

• COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS
  申请人：THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH

  公开号：US20160045514A1

  公开（公告）日：2016-02-18

  Described herein are compounds and compositions for the amelioration of arthritis or joint injuries by inducing mesenchymal stem cells into chondrocytes.

  本文描述了一种化合物和组合物，通过将间充质干细胞诱导为软骨细胞，用于改善关节炎或关节损伤的方法。
• Compounds and methods for inducing chondrogenesis
  申请人：The Scripps Research Institute

  公开号：US10166237B2

  公开（公告）日：2019-01-01

  The present invention provides compounds and compositions for the amelioration of arthritis and joint injuries by inducing mesenchymal stem cells into chondrocytes.

  本发明提供了通过诱导间充质干细胞转化为软骨细胞来改善关节炎和关节损伤的化合物和组合物。
• US9464065B2
  申请人：——

  公开号：US9464065B2

  公开（公告）日：2016-10-11
• US9452170B2
  申请人：——

  公开号：US9452170B2

  公开（公告）日：2016-09-27
• [EN] COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS<br/>[FR] COMPOSÉS ET PROCÉDÉS POUR L'INDUCTION DE LA CHONDROGENÈSE
  申请人：CALIFORNIA INST BIOMEDICAL RES

  公开号：WO2014151953A1

  公开（公告）日：2014-09-25

  Described herein are compounds and compositions for the amelioration of arthritis or joint injuries by inducing mesenchymal stem cells into chondrocytes.